Biology subjects

Zakeri, P.

Publications and source records attributed to Zakeri, P..

3 recordsLinked to original sources

bioRxiv2026

BfBio: a graph-based tool for the prediction of Angiogenic Stalk Cell genes using a Personalized PageRank algorithm

Although most human protein coding genes have functional annotations in databases, such as GeneCards, many remain poorly characterized. To address this gap, computational tools can be leveraged to predict the functional roles of under-annotated genes by extracting patterns from complex biological networks. Here we introduce Brain-for-Biotech (BfBio), a framework designed to identify genes important for vascular endothelial cells (EC), which are crucial cells for vessel formation (angiogenesis), vascular homeostasis, hemostasis and blood/tissue barrier function but also critical mediators of immunity and cancer progression. BfBio utilizes a Personalized PageRank (PPR) algorithm on an integrated network of different omics datasets and publicly available gene-gene/protein-protein interaction databases. In this study, we apply the predictive capabilities of BfBio to infer angiogenic stalk cell phenotype function in genes for which this function was not known before. By leveraging a set of genes characterizing the stalk cell cluster in lung tumor EC models previously identified, we have achieved a high Area Under Receiver Operative Characteristic (AUC-ROC) performance (0.837). Enrichment analysis, coupled with a text mining application, further confirmed that among the 49 predicted genes four of them were poorly characterized yet possessed biologically relevant properties and were linked to cancer, thereby validating BfBio as a robust tool for prioritizing novel therapeutic targets in vascular biology.

cancer biology↗

bioRxiv2020

Benchmarking joint multi-omics dimensionality reduction approaches for cancer study

High-dimensional multi-omics data are now standard in biology. They can greatly enhance our understanding of biological systems when effectively integrated. To achieve this multi-omics data integration, Joint Dimensionality Reduction (jDR) methods are among the most efficient approaches. However, several jDR methods are available, urging the need for a comprehensive benchmark with practical guidelines. We performed a systematic evaluation of nine representative jDR methods using three complementary benchmarks. First, we evaluated their performances in retrieving ground-truth sample clustering from simulated multi-omics datasets. Second, we used TCGA cancer data to assess their strengths in predicting survival, clinical annotations and known pathways/biological processes. Finally, we assessed their classification of multi-omics single-cell data. From these in-depth comparisons, we observed that intNMF performs best in clustering, while MCIA offers a consistent and effective behavior across many contexts. The full code of this benchmark is implemented in a Jupyter notebook - multi-omics mix (momix) - to foster reproducibility, and support data producers, users and future developers.

bioinformatics↗

bioRxiv2017

Mining therapeutic insights from large scale drug screenings with transfer learning

Despite the abundance of large-scale molecular and drug-response data, the insights gained about the mechanisms underlying treatment efficacy in cancer has been in general limited. Machine learning algorithms applied to those datasets most often are used to provide predictions without interpretation, or reveal single drug-gene association and fail to derive robust insights. We propose to use Macau, a bayesian multitask multi-relational algorithm to generalize from individual drugs and genes and explore the interactions between the drug targets and signaling pathways activation. A typical insight would be: \"Activation of pathway Y will confer sensitivity to any drug targeting protein X\". We applied our methodology to the Genomics of Drug Sensitivity in Cancer (GDSC) screening, using gene expression of 990 cancer cell lines, activity scores of 11 signaling pathways derived from the tool PROGENy as cell line input and 228 nominal targets for 265 drugs as drug input. These interactions can guide a tissue-specific combination treatment strategy, for example suggesting to modulate a certain pathway to maximize the drug response for a given tissue. We confirmed in literature drug combination strategies derived from our result for brain, skin and stomach tissues. Such an analysis of interactions across tissues might help target discovery, drug repurposing and patient stratification strategies.

bioinformatics↗